Canal Insurance CO Purchases 30,000 Shares of CVS Health Co. (NYSE:CVS)

Canal Insurance CO grew its holdings in CVS Health Co. (NYSE:CVSFree Report) by 15.0% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 230,000 shares of the pharmacy operator’s stock after acquiring an additional 30,000 shares during the period. CVS Health makes up 2.7% of Canal Insurance CO’s portfolio, making the stock its 13th biggest position. Canal Insurance CO’s holdings in CVS Health were worth $10,325,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the business. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health during the third quarter valued at $25,000. Ridgewood Investments LLC lifted its holdings in CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new position in CVS Health in the third quarter valued at about $31,000. Legacy Investment Solutions LLC bought a new stake in CVS Health during the third quarter worth about $31,000. Finally, Reston Wealth Management LLC acquired a new stake in shares of CVS Health during the third quarter worth approximately $32,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CVS. StockNews.com lowered CVS Health from a “hold” rating to a “sell” rating in a research report on Thursday, November 14th. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and raised their target price for the company from $60.00 to $66.00 in a research note on Monday, November 18th. TD Cowen upped their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. Mizuho lowered their price objective on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. Finally, Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. One research analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $68.12.

Get Our Latest Stock Report on CVS Health

CVS Health Stock Up 3.0 %

Shares of NYSE CVS opened at $56.20 on Tuesday. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market cap of $70.72 billion, a P/E ratio of 14.26, a P/E/G ratio of 0.80 and a beta of 0.59. The firm has a 50 day moving average price of $51.24 and a 200 day moving average price of $56.20.

CVS Health (NYSE:CVSGet Free Report) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. During the same quarter in the prior year, the business posted $2.21 EPS. The business’s revenue was up 6.3% compared to the same quarter last year. Analysts expect that CVS Health Co. will post 5.22 EPS for the current year.

CVS Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.73%. CVS Health’s payout ratio is presently 67.51%.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.